| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 725670 | 5,6-Dihydro-5,11-dioxo-6-(2-N-piperazine-1-ethyl)-11H-indeno [1,2-c]isoquinoline | 0.0314734733353267 | 0.52839141 |
| NSC 740564 | 6-(3-Aminopropyl)-9-fluoro-5,6-dihydro-2,3-dimethoxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride | 0.0314734733353267 | 0.67753964 |
| NSC 88903 | Null | 0.0314734733353267 | 0.34311589 |
| NSC 92915 | ANTINEOPLASTIC-92915 | 0.0314734733353267 | -0.045097026 |
| NSC 693248 | Null | 0.0329129886465387 | 0.26709908 |
| NSC 703784 | L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride | 0.0329129886465387 | 0.10852703 |
| NSC 709358 | 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol | 0.0329129886465387 | 0.42450868 |
| NSC 718564 | Null | 0.0329129886465387 | -0.023564118 |
| NSC 725098 | Null | 0.0329129886465387 | 0.49248958 |
| NSC 752344 | Null | 0.0329129886465387 | 0.067179011 |